ARCHIVES

Anil Potti Reprimanded by North Carolina Licensure Board

This article is from The Cancer Letter archive.

Vol. 37 No. 45 | December 9, 2011

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

NCI Programs: Pediatric Brain Tumor Grants Awarded

April 16, 1999

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

January 23, 2004